Blau Farmacêutica S.A. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was BRL 361.63 million compared to BRL 319.62 million a year ago. Net income was BRL 94.53 million compared to BRL 94.39 million a year ago. Basic earnings per share from continuing operations was BRL 0.42 compared to BRL 0.53 a year ago. Diluted earnings per share from continuing operations was BRL 0.42 compared to BRL 0.53 a year ago.
For the nine months, sales was BRL 1,040.21 million compared to BRL 1,016.51 million a year ago. Net income was BRL 268.39 million compared to BRL 280.05 million a year ago. Basic earnings per share from continuing operations was BRL 1.5092 compared to BRL 1.6623 a year ago. Diluted earnings per share from continuing operations was BRL 1.5092 compared to BRL 1.6623 a year ago.